These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8930956)

  • 21. Two actin binding proteins, actin depolymerizing factor and cofilin, are associated with Hirano bodies.
    Maciver SK; Harrington CR
    Neuroreport; 1995 Oct; 6(15):1985-8. PubMed ID: 8580423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship in the formation process between neurofibrillary tangles and Lewy bodies in the hippocampus of dementia with Lewy bodies brains.
    Iseki E; Takayama N; Marui W; Uéda K; Kosaka K
    J Neurol Sci; 2002 Mar; 195(1):85-91. PubMed ID: 11867079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of actin with Hirano bodies.
    Goldman JE
    J Neuropathol Exp Neurol; 1983 Mar; 42(2):146-52. PubMed ID: 6186777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology.
    Kadokura A; Yamazaki T; Lemere CA; Takatama M; Okamoto K
    Neuropathology; 2009 Oct; 29(5):566-73. PubMed ID: 19422539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical study of synphilin-1 in brains of patients with dementia with Lewy bodies - synphilin-1 is non-specifically implicated in the formation of different neuronal cytoskeletal inclusions.
    Iseki E; Takayama N; Furukawa Y; Marui W; Nakai T; Miura S; Uéda K; Kosaka K
    Neurosci Lett; 2002 Jul; 326(3):211-5. PubMed ID: 12095658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hippocampal cholinergic neurostimulating peptides (HCNP).
    Ojika K; Mitake S; Tohdoh N; Appel SH; Otsuka Y; Katada E; Matsukawa N
    Prog Neurobiol; 2000 Jan; 60(1):37-83. PubMed ID: 10622376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Derlin-1-immunopositive inclusions in patients with Alzheimer's disease.
    Honjo Y; Ito H; Horibe T; Shimada H; Nakanishi A; Mori H; Takahashi R; Kawakami K
    Neuroreport; 2012 Jul; 23(10):611-5. PubMed ID: 22627700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Function of HCNP/HCNP precursor in memory formation].
    Matsukawa N; Ojika K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Nov; 26(5-6):219-27. PubMed ID: 17240848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Casein kinase II alteration precedes tau accumulation in tangle formation.
    Masliah E; Iimoto DS; Mallory M; Albright T; Hansen L; Saitoh T
    Am J Pathol; 1992 Feb; 140(2):263-8. PubMed ID: 1739121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of HCNP-related antigens in hippocampus in senescence-accelerated mice.
    Yamada K; Matsukawa N; Yuasa H; Hattori M; Nakazawa H; Borlongan CV; Ojika K
    Brain Res; 2007 Jul; 1158():169-75. PubMed ID: 17570350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylation of collapsin response mediator protein-2 regulates its localization and association with hippocampal cholinergic neurostimulating peptide precursor in the hippocampus.
    Mizuno M; Kato D; Kanamori T; Toyoda T; Suzuki T; Ojika K; Matsukawa N
    Neurosci Lett; 2013 Feb; 535():122-7. PubMed ID: 23276635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hirano bodies accumulate C-terminal sequences of beta-amyloid precursor protein (beta-APP) epitopes.
    Munoz DG; Wang D; Greenberg BD
    J Neuropathol Exp Neurol; 1993 Jan; 52(1):14-21. PubMed ID: 7678852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuronal distribution and subcellular localization of HCNP-like immunoreactivity in rat small intestine.
    Katada E; Ojika K; Mitake S; Ueda R
    J Neurocytol; 2000 Mar; 29(3):199-207. PubMed ID: 11428049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transgenic mouse model for the formation of Hirano bodies.
    Ha S; Furukawa R; Stramiello M; Wagner JJ; Fechheimer M
    BMC Neurosci; 2011 Oct; 12():97. PubMed ID: 21978358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hirano body expression impairs spatial working memory in a novel mouse model.
    Furgerson M; Clark JK; Crystal JD; Wagner JJ; Fechheimer M; Furukawa R
    Acta Neuropathol Commun; 2014 Sep; 2():131. PubMed ID: 25178488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.
    Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE
    Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progressive neuronal DNA damage associated with neurofibrillary tangle formation in Alzheimer disease.
    Sheng JG; Mrak RE; Griffin WS
    J Neuropathol Exp Neurol; 1998 Apr; 57(4):323-8. PubMed ID: 9600224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct determination of the proportion of intra- and extra-cellular neocortical neurofibrillary tangles in Alzheimer's disease.
    Vickers JC; Tan A; Dickson TC
    Brain Res; 2003 May; 971(1):135-7. PubMed ID: 12691846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ubiquilin-1 immunoreactivity is concentrated on Hirano bodies and dystrophic neurites in Alzheimer's disease brains.
    Satoh J; Tabunoki H; Ishida T; Saito Y; Arima K
    Neuropathol Appl Neurobiol; 2013 Dec; 39(7):817-30. PubMed ID: 23421764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hirano body filaments contain actin and actin-associated proteins.
    Galloway PG; Perry G; Gambetti P
    J Neuropathol Exp Neurol; 1987 Mar; 46(2):185-99. PubMed ID: 3029338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.